TABLE 2

Covalent binding and metabolic conversion of [14C]rimonabant in human liver microsomal incubations with and without reactive metabolite trapping agents

Test CompoundTrapperNADPH (Yes/No)Covalent Binding ± S.D.aConversionbCorrected Covalent BindingcFraction Covalent Bindingd
pmol eq/mg protein%pmol eq/mg protein
[14C]RimonabantNo trapperYes920 ± 24499200.19
No trapperNo10 ± 0.3NANANA
CyanideYes432 ± 17375780.12
GlutathioneYes811 ± 59478510.17
MethoxylamineYes182 ± 6.1146330.13
  • NA, not applicable.

  • a Means of three incubations ± S.D.

  • b Metabolic conversion of [14C]rimonabant measured by LC-RAD.

  • c Covalent binding values measured in the incubations with trappers are corrected for the difference in percentage conversion of parent compared with the no trapper incubation with NADPH [i.e. corrected covalent binding = (covalent binding in the presence of trapper/conversion in the presence of trapper) × conversion in the absence of trapper].

  • d The fraction covalent binding is calculated as follows: fCVB = covalent binding × protein concentration/(total radioactivity in incubation × conversion).